IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i2p1361-d1032837.html
   My bibliography  Save this article

Positive Impacts of a Four-Week Neuro-Meditation Program on Cognitive Function in Post-Acute Sequelae of COVID-19 Patients: A Randomized Controlled Trial

Author

Listed:
  • Christophe Hausswirth

    (LAMHESS, Université Côte d’Azur, EA6312, 06205 Nice, France
    BeScored Institute, Valbonne Sophia Antipolis, 06560 Valbonne, France
    Faculty of Health, University of Technology (UTS), Sydney, NSW 2007, Australia)

  • Cyril Schmit

    (BeScored Institute, Valbonne Sophia Antipolis, 06560 Valbonne, France)

  • Yann Rougier

    (WHealth Found, 06270 Villeneuve-Loubet, France)

  • Alexandre Coste

    (BeScored Institute, Valbonne Sophia Antipolis, 06560 Valbonne, France)

Abstract

Study objective: Long COVID patients can experience high levels of impairment in their cognitive function and mental health. Using a parallel randomized control trial, we evaluated the effectiveness of a neuro-meditation program to reduce cognitive impairment in patients with long COVID. Methods: A total of 34 patients with long COVID were randomized to an intervention group (G-Int; n = 17) or a control group (G-Con; n = 17) and 15 healthy participants were constitutive of a normative group (G-Nor). The intervention consisted of ten 30-min sessions of Rebalance ® over a period of five weeks. Each session included sound therapy and coach-guided meditation associated with light stimulations (i.e., chromotherapy). Primary outcomes were performance on five computerized cognitive tasks ( choice response time , pattern comparison , Simon, pursuit rotor task , and Corsi block-tapping task ), mental and physical fatigue ( Chalder fatigue scale ), perceived stress ( perceived stress scale ) and mood ( profiles of mood states ). Secondary outcomes were anxiety and depressive symptoms ( hospital anxiety and depression scale ), muscular pain, joint pain, and headaches using visual analog scales ( VAS ) as well as sleep quality ( Spiegel sleep questionnaire ). Assessments were conducted at baseline and at 1–2 and 7–8 days of follow-up. Results: Compared to healthy subjects, long COVID patients showed significant differences at baseline on all the self-report questionnaires, and a Rebalance ® program improved all the subjective reports, as well as cognitive performances, especially on reaction time-based tasks. In particular, only the G-Int group revealed shortened reaction times in the choice reaction time (RT baseline = 593 ± 121 ms vs. RT post2 = 521 ± 86 ms, p < 0.001), Simon (RT baseline = 539 ± 123 ms vs. RT post2 = 494 ± 134 ms, p < 0.01), and pattern comparison tasks (RT baseline = 1244 ± 315 ms vs. RT post2 = 1079 ± 213 ms, p < 0.001). Conclusions) Initial evidence suggests that neuro-meditation reduces cognitive impairment and improves physical and mental fatigue, muscle and joint pain, symptoms of depression and anxiety, mood disturbances as well as sleep quality. The Rebalance ® program hence constitutes a promising non-pharmacological intervention for the treatment of long-term psychological/cognitive outcomes of COVID-19.

Suggested Citation

  • Christophe Hausswirth & Cyril Schmit & Yann Rougier & Alexandre Coste, 2023. "Positive Impacts of a Four-Week Neuro-Meditation Program on Cognitive Function in Post-Acute Sequelae of COVID-19 Patients: A Randomized Controlled Trial," IJERPH, MDPI, vol. 20(2), pages 1-16, January.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:2:p:1361-:d:1032837
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/2/1361/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/2/1361/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Gwenaëlle Douaud & Soojin Lee & Fidel Alfaro-Almagro & Christoph Arthofer & Chaoyue Wang & Paul McCarthy & Frederik Lange & Jesper L. R. Andersson & Ludovica Griffanti & Eugene Duff & Saad Jbabdi & Be, 2022. "SARS-CoV-2 is associated with changes in brain structure in UK Biobank," Nature, Nature, vol. 604(7907), pages 697-707, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Cunwei Yang & Weiqing Wang & Fengying Li & Degang Yang, 2022. "One-Size-Fits-All Policies Are Unacceptable: A Sustainable Management and Decision-Making Model for Schools in the Post-COVID-19 Era," IJERPH, MDPI, vol. 19(10), pages 1-21, May.
    2. Samuel Hurtado & Mario Izquierdo, 2023. "Economic effects of a possible prolonged deterioration in the general health of the Spanish population," Economic Bulletin, Banco de España, issue 2023/Q1.
    3. Carlos Eduardo Covantes-Rosales & Victor Wagner Barajas-Carrillo & Daniel Alberto Girón-Pérez & Gladys Alejandra Toledo-Ibarra & Karina Janice Guadalupe Díaz-Reséndiz & Migdalia Sarahy Navidad-Murriet, 2022. "Comparative Analysis of Age, Sex, and Viral Load in Outpatients during the Four Waves of SARS-CoV-2 in A Mexican Medium-Sized City," IJERPH, MDPI, vol. 19(9), pages 1-9, May.
    4. Yirui Ma & Jie Deng & Qiao Liu & Min Du & Min Liu & Jue Liu, 2022. "Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis," IJERPH, MDPI, vol. 19(11), pages 1-16, June.
    5. Caitlin E. Carey & Rebecca Shafee & Robbee Wedow & Amanda Elliott & Duncan S. Palmer & John Compitello & Masahiro Kanai & Liam Abbott & Patrick Schultz & Konrad J. Karczewski & Samuel C. Bryant & Caro, 2024. "Principled distillation of UK Biobank phenotype data reveals underlying structure in human variation," Nature Human Behaviour, Nature, vol. 8(8), pages 1599-1615, August.
    6. Dominika Tatar & Krzysztof Świerzy & Michał Błachut & Karina Badura Brzoza, 2022. "Psychotic Disorders in the Course of SARS-CoV-2 Infection or Uncomplicated Amantadine Treatment?—Case Report," IJERPH, MDPI, vol. 19(23), pages 1-7, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:2:p:1361-:d:1032837. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.